|
Volumn 138, Issue 1, 2016, Pages 286-289.e9
|
Vitamin D3 treatment of vitamin D–insufficient asthmatic patients does not alter immune cell function
|
Author keywords
[No Author keywords available]
|
Indexed keywords
25 HYDROXYVITAMIN D 3 1ALPHA HYDROXYLASE;
COLECALCIFEROL;
CORTICOSTEROID;
GAMMA INTERFERON;
HLA DR ANTIGEN;
INTERLEUKIN 10;
INTERLEUKIN 12P40;
INTERLEUKIN 17;
INTERLEUKIN 2;
INTERLEUKIN 4;
INTERLEUKIN 6;
TUMOR NECROSIS FACTOR;
UNCLASSIFIED DRUG;
VITAMIN D RECEPTOR;
IFNG PROTEIN, HUMAN;
INTERLEUKIN DERIVATIVE;
TRANSFORMING GROWTH FACTOR BETA;
ARTICLE;
ASTHMA;
CD4+ T LYMPHOCYTE;
CYTOKINE RELEASE;
HUMAN;
IMMUNOCOMPETENT CELL;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
VITAMIN D DEFICIENCY;
COMPLICATION;
CONTROLLED STUDY;
DENDRITIC CELL;
DRUG EFFECT;
GENE EXPRESSION;
GENETICS;
IMMUNOLOGY;
METABOLISM;
MONOCYTE;
RANDOMIZED CONTROLLED TRIAL;
ADRENAL CORTEX HORMONES;
ASTHMA;
CD4-POSITIVE T-LYMPHOCYTES;
CHOLECALCIFEROL;
DENDRITIC CELLS;
GENE EXPRESSION;
HUMANS;
INTERFERON-GAMMA;
INTERLEUKINS;
MONOCYTES;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR-ALPHA;
VITAMIN D DEFICIENCY;
|
EID: 84957921696
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2015.11.030 Document Type: Article |
Times cited : (7)
|
References (9)
|